EXHIBIT 6.2
November 24, 1999
▇▇. ▇▇▇▇▇▇ ▇. ▇▇▇▇
Chairman
Clinical Chemistry Holdings, Inc.
▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇
▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Dear ▇▇. ▇▇▇▇:
The letter agreement between ▇▇▇▇▇▇ Investment Strategies, Inc.
("▇▇▇▇▇▇"), Clinical Chemistry Holdings, Inc. ("CCH"), and ▇▇▇▇▇▇ ▇. ▇▇▇▇, dated
November 12, 1999 ("Letter Agreement"), is modified and amended by the deletion
of the first numbered paragraph thereof and the insertion of the following in
its place:
1. Effective November 24, 1999 (the "Effective Date"), ▇▇▇▇▇▇
Investment Strategies, Inc. ("▇▇▇▇▇▇") shall transfer to Clinical
Chemistry Holdings, Inc. ("CCH"), and CCH shall purchase from ▇▇▇▇▇▇,
on an all or none basis, 185,533 shares of Common Stock of Novitron
International, Inc. ("Novitron") held by ▇▇▇▇▇▇ and various accounts
over which ▇▇▇▇▇▇ has dispositive power ("Shares"). The total
consideration to be paid by CCH to ▇▇▇▇▇▇ for the transfer of the
Shares shall be Five Hundred Fifty-six Thousand Five Hundred
Ninety-nine Dollars ($556,599.00), which is calculated on the basis of
$3.00 per Share. Payment shall be made upon delivery of the Shares to
the broker designated by CCH. "Closing shall have occurred upon
completion of the delivery of the Shares and the payment therefor as
described above. Upon Closing, paragraphs two, four, and five of this
letter shall be effective as of the Effective Date.
Except as modified and amended in this letter, the Letter Agreement
shall remain in full force and effect. If you are in agreement with the above,
please execute this amendment to the Letter Agreement and return a signed copy
to the undersigned at the address indicated above.
▇▇▇▇▇▇ INVESTMENT STRATEGIES, INC.
By: /s/ ▇▇▇ ▇▇▇▇▇▇
---------------------------------
▇▇▇ ▇▇▇▇▇▇, President
Page 15 of 21 Pages
CLINICAL CHEMISTRY HOLDINGS, INC.
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇
---------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇, Chairman
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇
---------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇, Individually
Page 16 of 21 Pages
